ACS Systems Improving Delivery of Healthcare in Malta

iSOFTAffiliated Computer Services, Inc. announced that it has successfully completed Phase I of the Government of Malta's Integrated Health Information System (IHIS), program to attain the highest quality patient care for the citizens of Malta.

Along with iSOFT, a key technology partner, ACS has installed state-of-the-art IT infrastructure that connects laboratory, radiology, and image archiving communication systems and integrates them with iSOFT's Patient Administration System and Clinical Order Communication and Results Reporting System. The systems have already helped improve the delivery and management of healthcare service and records in Malta's new 850-bed Mater Dei Hospital, the nation's largest healthcare facility. ACS will also provide ongoing operations, maintenance, and integration services and support through an on-site command center.

"The rapid implementation of this system was designed to provide quick benefits to the citizens of Malta," said Charles Bracken, managing director of ACS Healthcare Solutions. "Not only were we required to install new digital technology, but laboratory and radiology services had to be completely updated in the process, and all of this needed to happen while Mater Dei Hospital was moving to a new campus."

"By developing and deploying important IT partnerships, we were able to meet our aggressive deadlines. We transferred our healthcare knowledge to the Government of Malta in record time. Now we look forward to leveraging our global healthcare experience and expertise to help Mater Dei Hospital provide world-class care to those who need it most," he said.

Mater Dei's 150 laboratory scientists conduct 4.5 million tests each year for healthcare professionals throughout Malta. Replacing largely manual processes, iSOFT's i.Laboratory systems will speed the turnaround of test results, increase the accuracy of test data and patient information, enhance the legibility of critical reports, and provide better access to patient demographics and specimen records, all improving the quality and efficiency of healthcare delivery.

"Meticulous planning and great team work with ACS enabled us to meet an urgent customer need," said Paul Richards, managing director of iSOFT in the United Kingdom and Ireland. "This implementation took less than five months to complete, which is a considerable achievement for a project of this scale and complexity."

i.Laboratory also allows tests, samples, and results to be tracked across all of the hospital's laboratories, including chemistry, haematology, immunology, microbiology, virology, toxicology, pathology, and cytology. Ultimately every ward within Mater Dei will be able to order tests and view the results online.

Related news articles:

About iSOFT
iSOFT is an IBA Health Group company.

IBA Health Group Limited is the largest specialist information technology company listed on the Australian Securities Exchange. Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market, and anticipation of evolving requirements. Its business is driven by the collective talent, experience, and commitment of over 3,500 healthcare IT experts around the globe. A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result IBA offers its customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation, and organisational structure.

About ACS
ACS, a global FORTUNE 500 company with 62,000 people supporting client operations reaching more than 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The company's Class A common stock trades on the New York Stock Exchange under the symbol "ACS". Learn more about ACS at www.acs-inc.com.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...